Chapter 16 The human hypothalamo-neurohypophyseal system in relation to development, aging and Alzheimer's disease (Q59449741)

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Vasopressin and oxytocin—their role in neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Oxytocin, vasopressin and neurophysins in the hypothalamo-neurohypophysial system of the human fetus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Exposure to light in healthy elderly subjects and alzheimer's patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Organization of lateral geniculate-hypothalamic connections in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Pathological Changes During Aging in, Barrier-Reared Fischer 344 Male Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Reflex control of magnocellular vasopressin and oxytocin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Neuropeptides, mental performance and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Immunocytochemical localization of the vasopressinergic and the oxytocinergic neurons in the human hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Activation of vasopressinergic and oxytocinergic neurons during aging in the Wistar rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

The vasopressin and oxytocin neurons in the human supraoptic and paraventricular nucleus; changes with aging and in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Neurohypophyseal responsiveness in the normal and senescent rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Vasopressin and cardiovascular system in aging

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Effect of ageing on cyclic AMP output by renal medullary cells in response to arginine vasopressin in vitro in C57BL/Icrfat mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Vasopressin and oxytocin excretion in the Brown-Norway rat in relation to aging, water metabolism and testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Early light microscopic changes in chronic progressive nephrosis in several strains of aging laboratory rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

The Response of Arginine Vasopressin to Intravenous Ethanol and Hypertonic Saline in Man: The Impact of Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Testosterone treatment restores reduced vasopressin-binding sites in the kidney of the ageing rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Optic-nerve degeneration in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Activation of vasopressin neurons in the human supraoptic and paraventricular nucleus in senescence and senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Hypothalamic neuron number of old female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Loss of entrainment and anatomical plasticity after lesions of the hamster retinohypothalamic tract

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Plasma arginine vasopressin in dehydrated elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

The radioimmunoassay of human neurophysins: contribution to the understanding of the physiopathology of neurohypophyseal function

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Influence of vasopressin on learning and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Supraoptic neurones of rat hypothalamus are osmosensitive

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

CSF vasopressin concentration is reduced in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Age differences in the renal tubular response to antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Increased vasopressin secretion: an early manifestation of aging in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Retinohypothalamic projection in mammals: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Amniotic oxytocin and vasopressin in relation to human fetal development and labour

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Evidence of age-related variation in plasma vasopressin of normotensive men

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

No neuron loss from hypothalamic nuclei of old male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Vasopressin in aged rats: longitudinal studies of vasopressin excretion in Sprague-Dawley and Fischer 344 strains

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Reduced thirst after water deprivation in healthy elderly men.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

The suprachiasmatic nuclei: two circadian clocks?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and beta-endorphin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Changes in vasopressin and testosterone in the senescent brown-Norway (BN/BiRij) rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Localization and regulation of vasopressin mRNA in human neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Changes in vasopressin cells of the rat suprachiasmatic nucleus with aging

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

The influence of age on the renal response to water deprivation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Neural regulation of circadian rhythms

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Vasopressin and renin response to dehydration in aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

CSF and plasma vasopressin concentrations in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Cerebrospinal fluid vasopressin in neurological and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Brain aging and Alzheimer's disease, “Wear and tear” versus “Use it or lose it”

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretory system of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Efferent projections of the suprachiasmatic nucleus: I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Co-localization of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Oxytocin cell number in the human paraventricular nucleus remains constant with aging and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

Neurohypophyseal aging: differential changes in oxytocin and vasopressin release, studied in Fischer 344 and Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

The effect of aging on vasopressin system in Fisher 344 rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2964575-6

7 January 2021